MedPath
HSA Approval

FULVESTRANT EVER PHARMA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 250MG/5ML

SIN17045P

FULVESTRANT EVER PHARMA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 250MG/5ML

FULVESTRANT EVER PHARMA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 250MG/5ML

July 12, 2024

ALLIANCE PHARM PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantALLIANCE PHARM PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAMUSCULAR

Medical Information

L02BA03

Manufacturer Information

ALLIANCE PHARM PTE. LTD.

EVER Pharma Jena GmbH

Active Ingredients

Fulvestrant

250mg/5mL

Fulvestrant

Documents

Package Inserts

Fulvestrant Ever Pharma Package Insert.pdf

Approved: July 12, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FULVESTRANT EVER PHARMA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 250MG/5ML - HSA Approval | MedPath